
Shine: a podcast by Star
Hosted by Star
Welcome to Shine: a podcast by Star. Here you will get actionable insider knowledge directly from globally leading industry experts and companies. We answer essential questions and take a deep look into technology and design thinking within Star core industries: Health & Wellness, Automotive & Mobility, and Fintech.
34 episodes · publishes monthly · latest 2024-09-25
Rank
#0
Substance
39.3
/ 100
Why it scores where it does
Shine: a podcast by Star ranks #0 on The B2B Podcast Index with a substance score of 39.3 out of 100, scored across 3 recent episodes. It scores highest on specificity & evidence and insight density. The road-marking object-detection anecdote (network learning signposts as a proxy for dashed lines) and the expensive-scanner MedTech bias example are concrete and illuminating; regulatory references to Annex 1 and Annex 3 of the EU AI Act add some precision, but there are no dollar figures, client names, timelines, or quantitative outcomes anywhere in the episode.
The five-dimension breakdown
Averaged across 3 recently scored episodes, with cited evidence.
Insight Density
9.0 / 20The episode contains a handful of genuinely non-obvious ideas—compliance narrowing the solution space to accelerate development, non-determinism in ML requiring statistical rather than functional QA, and the data-extraction risk from trained models—but these are diluted by substantial filler, mutual agreement loops, and repetition of 'start small, start early.'
“compliance takes away certain dimensions you don't have to explore anymore because they're already, let's say, defined or limited”
“companies start using a second AI system to assess the quality of the first AI system, which seems to reasonable but also is actually creating a kind of recursion”
Originality
6.0 / 20The framing of compliance as a creative constraint that speeds innovation is a mild counter-intuitive take, and the parallel between ISMS behavioural trust and AI governance is a fresh analogy, but the bulk of the episode recycles familiar 'AI Act is coming, start small, manage bias' narratives without first-principles reasoning.
“if compliance is established early… it actually can speed up the development”
“in cybersecurity you have to trust on the behavior of people… it's the same with AI”
Guest Caliber
9.0 / 20Both guests are internal staff at the producing company—a technical director and a head of regulatory compliance—who show genuine practitioner knowledge (medical device submissions, hands-on ML bias debugging) but are not independent operators who have built and scaled AI-governed products externally; the episode is essentially an in-house explainer.
“as of now, I support a team. We support many companies with medical device submissions to regulators”
“one of our previous companies where we were doing machine learning, so before the, before it was called AI area”
Specificity & Evidence
9.7 / 20The road-marking object-detection anecdote (network learning signposts as a proxy for dashed lines) and the expensive-scanner MedTech bias example are concrete and illuminating; regulatory references to Annex 1 and Annex 3 of the EU AI Act add some precision, but there are no dollar figures, client names, timelines, or quantitative outcomes anywhere in the episode.
“the network actually learned not to detect dashed lines, but signposts which were beside the road, because there was a correlation between signposts and dashed lines”
“system learned to detect if the image was coming from more expensive scanner, it learned that most likely this person will have some condition”
Conversational Craft
5.7 / 20The format is two colleagues who largely affirm each other's views, with questions that are frequently leading ('Would you agree that…?', 'Am I correct that…?') and no meaningful pushback or challenge; the one stronger question about whether AIMS helps when a bias is found post-release is the clearest example of productive probing but remains isolated.
“Does it make a difference or does it help you that you have followed AI Ms. Procedures compared to a company which doesn't have an AIMS in place and ends up in the same situation?”
“Am I correct that this also falls under regulatory clients needs?”
Standout episodes
- 45
- 37
- 36
Rank over time
First period on the Index - history builds from here.
Episodes
3 scored on substance · 34 tracked in total.